| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
|
| | LAVENDUSTIN C Basic information |
| | LAVENDUSTIN C Chemical Properties |
| Melting point | 193-195°C dec. | | Boiling point | 597.5±50.0 °C(Predicted) | | density | 1.551±0.06 g/cm3(Predicted) | | storage temp. | −20°C | | solubility | DMSO: soluble | | form | solid | | pka | 2.32±0.10(Predicted) | | color | Light Beige to Brown | | Stability: | Hygroscopic |
| | LAVENDUSTIN C Usage And Synthesis |
| Description | Lavendustin C, a derivative of a Streptomyces griseolavendus butyl acetate extract, is a potent inhibitor of epidermal growth factor (EGF) receptor-associated tyrosine kinase with an IC50 value of 0.012 μM. Lavendustin C also inhibits pp60c-src(+) kinase and Ca2+ calmodulin-dependent kinase II with IC50 values of 0.5 and 0.2 μM, respectively. At a concentration of 10-150 μM, lavendustin C inhibits tyrosine kinase-associated neutrophil degranulation and superoxide generation. | | Chemical Properties | Brown Solid | | Uses | Shows potent tyrosine kinase inhibitory activity. | | Definition | ChEBI: 5-[(2,5-dihydroxyphenyl)methylamino]-2-hydroxybenzoic acid is an aromatic amine. | | IC 50 | CaMK II: 0.2 μM (IC50); EGFR: 0.012 μM (IC50) | | References | [1] HELEN M. BURT Hassan S John K Jackson. Inhibition of crystal-induced neutrophil activation by a protein tyrosine kinase inhibitor[J]. Journal of Leukocyte Biology, 1994, 55 1: 112-119. DOI: 10.1002/jlb.55.1.112 |
| | LAVENDUSTIN C Preparation Products And Raw materials |
|